I agree getting the 300 patients reduced to 30 is significant, however it looks like the criteria is the problem. I don't understand how they let the protocol be such a narrow window. It sounds like there is no shortage of people who want in on the trials, unfortunately they just aren't in bad enough shape.
I'm 100% behind that, Anthony C realizes that we have to hit the reset button on the investors and this is it, no more unrealistic expectations. Credibility has got to priority at this current state.